Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study

Naomi K. Tepper, Sherry L. Farr, Susan P. Danner, Robert Maupin, Steven R. Nesheim, Mardge H. Cohen, Yvette A. Rivero, Mayris P. Webber, Marc Bulterys, Michael K. Lindsay, Denise J. Jamieson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To evaluate the acceptability and feasibility of rapid human immunodeficiency virus testing in obstetric outpatient settings. Study Design: The Mother-Infant Rapid Intervention at Delivery (MIRIAD) study was a prospective, multicenter study. Women were offered rapid and conventional human immunodeficiency virus testing if they presented to outpatient settings late in pregnancy with undocumented human immunodeficiency virus status. We compared median times between conventional and rapid testing and between rapid point-of-care and rapid laboratory-based testing. Results: Among eligible women who were offered participation, 90% accepted testing. The median time from blood draw to result available was faster for rapid testing (25 minutes) than conventional testing (23 hours; P < .0001). For rapid tests, point-of-care testing was faster than laboratory-based testing (24 minutes vs 35 minutes; P < .0001). Almost 96% of rapid test results were available within 1 hour. Conclusion: Rapid human immunodeficiency virus testing is acceptable, feasible, and provides results far sooner than conventional testing in obstetric outpatient settings.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume201
Issue number1
DOIs
StatePublished - Jul 2009

Fingerprint

Obstetrics
Outpatients
Mothers
HIV
Point-of-Care Systems
Multicenter Studies
Prospective Studies
Pregnancy

Keywords

  • human immunodeficiency virus
  • outpatient settings
  • rapid testing

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Tepper, N. K., Farr, S. L., Danner, S. P., Maupin, R., Nesheim, S. R., Cohen, M. H., ... Jamieson, D. J. (2009). Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study. American Journal of Obstetrics and Gynecology, 201(1). https://doi.org/10.1016/j.ajog.2009.02.023

Rapid human immunodeficiency virus testing in obstetric outpatient settings : the MIRIAD study. / Tepper, Naomi K.; Farr, Sherry L.; Danner, Susan P.; Maupin, Robert; Nesheim, Steven R.; Cohen, Mardge H.; Rivero, Yvette A.; Webber, Mayris P.; Bulterys, Marc; Lindsay, Michael K.; Jamieson, Denise J.

In: American Journal of Obstetrics and Gynecology, Vol. 201, No. 1, 07.2009.

Research output: Contribution to journalArticle

Tepper, NK, Farr, SL, Danner, SP, Maupin, R, Nesheim, SR, Cohen, MH, Rivero, YA, Webber, MP, Bulterys, M, Lindsay, MK & Jamieson, DJ 2009, 'Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study', American Journal of Obstetrics and Gynecology, vol. 201, no. 1. https://doi.org/10.1016/j.ajog.2009.02.023
Tepper, Naomi K. ; Farr, Sherry L. ; Danner, Susan P. ; Maupin, Robert ; Nesheim, Steven R. ; Cohen, Mardge H. ; Rivero, Yvette A. ; Webber, Mayris P. ; Bulterys, Marc ; Lindsay, Michael K. ; Jamieson, Denise J. / Rapid human immunodeficiency virus testing in obstetric outpatient settings : the MIRIAD study. In: American Journal of Obstetrics and Gynecology. 2009 ; Vol. 201, No. 1.
@article{5bba12aee397427e8d65c25a1ae6a5dd,
title = "Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study",
abstract = "Objective: To evaluate the acceptability and feasibility of rapid human immunodeficiency virus testing in obstetric outpatient settings. Study Design: The Mother-Infant Rapid Intervention at Delivery (MIRIAD) study was a prospective, multicenter study. Women were offered rapid and conventional human immunodeficiency virus testing if they presented to outpatient settings late in pregnancy with undocumented human immunodeficiency virus status. We compared median times between conventional and rapid testing and between rapid point-of-care and rapid laboratory-based testing. Results: Among eligible women who were offered participation, 90{\%} accepted testing. The median time from blood draw to result available was faster for rapid testing (25 minutes) than conventional testing (23 hours; P < .0001). For rapid tests, point-of-care testing was faster than laboratory-based testing (24 minutes vs 35 minutes; P < .0001). Almost 96{\%} of rapid test results were available within 1 hour. Conclusion: Rapid human immunodeficiency virus testing is acceptable, feasible, and provides results far sooner than conventional testing in obstetric outpatient settings.",
keywords = "human immunodeficiency virus, outpatient settings, rapid testing",
author = "Tepper, {Naomi K.} and Farr, {Sherry L.} and Danner, {Susan P.} and Robert Maupin and Nesheim, {Steven R.} and Cohen, {Mardge H.} and Rivero, {Yvette A.} and Webber, {Mayris P.} and Marc Bulterys and Lindsay, {Michael K.} and Jamieson, {Denise J.}",
year = "2009",
month = "7",
doi = "10.1016/j.ajog.2009.02.023",
language = "English (US)",
volume = "201",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Rapid human immunodeficiency virus testing in obstetric outpatient settings

T2 - the MIRIAD study

AU - Tepper, Naomi K.

AU - Farr, Sherry L.

AU - Danner, Susan P.

AU - Maupin, Robert

AU - Nesheim, Steven R.

AU - Cohen, Mardge H.

AU - Rivero, Yvette A.

AU - Webber, Mayris P.

AU - Bulterys, Marc

AU - Lindsay, Michael K.

AU - Jamieson, Denise J.

PY - 2009/7

Y1 - 2009/7

N2 - Objective: To evaluate the acceptability and feasibility of rapid human immunodeficiency virus testing in obstetric outpatient settings. Study Design: The Mother-Infant Rapid Intervention at Delivery (MIRIAD) study was a prospective, multicenter study. Women were offered rapid and conventional human immunodeficiency virus testing if they presented to outpatient settings late in pregnancy with undocumented human immunodeficiency virus status. We compared median times between conventional and rapid testing and between rapid point-of-care and rapid laboratory-based testing. Results: Among eligible women who were offered participation, 90% accepted testing. The median time from blood draw to result available was faster for rapid testing (25 minutes) than conventional testing (23 hours; P < .0001). For rapid tests, point-of-care testing was faster than laboratory-based testing (24 minutes vs 35 minutes; P < .0001). Almost 96% of rapid test results were available within 1 hour. Conclusion: Rapid human immunodeficiency virus testing is acceptable, feasible, and provides results far sooner than conventional testing in obstetric outpatient settings.

AB - Objective: To evaluate the acceptability and feasibility of rapid human immunodeficiency virus testing in obstetric outpatient settings. Study Design: The Mother-Infant Rapid Intervention at Delivery (MIRIAD) study was a prospective, multicenter study. Women were offered rapid and conventional human immunodeficiency virus testing if they presented to outpatient settings late in pregnancy with undocumented human immunodeficiency virus status. We compared median times between conventional and rapid testing and between rapid point-of-care and rapid laboratory-based testing. Results: Among eligible women who were offered participation, 90% accepted testing. The median time from blood draw to result available was faster for rapid testing (25 minutes) than conventional testing (23 hours; P < .0001). For rapid tests, point-of-care testing was faster than laboratory-based testing (24 minutes vs 35 minutes; P < .0001). Almost 96% of rapid test results were available within 1 hour. Conclusion: Rapid human immunodeficiency virus testing is acceptable, feasible, and provides results far sooner than conventional testing in obstetric outpatient settings.

KW - human immunodeficiency virus

KW - outpatient settings

KW - rapid testing

UR - http://www.scopus.com/inward/record.url?scp=67649503179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649503179&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2009.02.023

DO - 10.1016/j.ajog.2009.02.023

M3 - Article

C2 - 19398094

AN - SCOPUS:67649503179

VL - 201

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -